T1INTERNATIONAL USA's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.

T1INTERNATIONAL USA

Latest quarter: No record; Q3 2026 · 0 reports
Last 12 months: $0; Last 4 quarters
vs last quarter: No record; Q3 2026 against the quarter before
First report: Q4 2022; The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

T1INTERNATIONAL USA lobbying by quarter
Quarter	Amount	Reports
Q4 2022	$0	1
Q1 2023	$0	1
Q2 2023	$0	1
Q3 2023	$0	1
Q4 2023	$0	1
Q1 2024	$0	1
Q2 2024	$0	1
Q3 2024	$0	1
Q4 2024	$0	1
Q1 2025	$0	1
Q2 2025	$0	1
Q3 2025	$0	1
Q4 2025	$0	1
Q1 2026	$0	1
Q2 2026	$0	1
Q3 2026	$0	0

By issue

Health issues$0 · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

SENATE14 reports
HOUSE OF REPRESENTATIVES11 reports
Federal Trade Commission (FTC)4 reports

Firms it paid

Firm
In-houseT1INTERNATIONAL USA	$0	15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

	Filed by		Issues
07/15for Q2	In-house	Under $5,000	Health issues
04/20for Q1	In-house	Under $5,000	Health issues
01/19for Q4 2025	In-house	Under $5,000	Health issues
25/10/15for Q3 2025	In-house	Under $5,000	Health issues
25/07/17for Q2 2025	In-house	Under $5,000	Health issues
25/04/08for Q1 2025	In-house	Under $5,000	Health issues
25/03/12for Q2 2024	In-house	Under $5,000	Health issues
25/01/10for Q4 2024	In-house	Under $5,000	Health issues
24/10/10for Q3 2024	In-house	Under $5,000	Health issues
24/07/16for Q2 2024	In-house	Under $5,000	Health issues
24/04/19for Q1 2024	In-house	Under $5,000	Health issues
24/01/11for Q4 2023	In-house	Under $5,000	Health issues
23/10/12for Q3 2023	In-house	Under $5,000	Health issues
23/07/14for Q2 2023	In-house	Under $5,000	Health issues
23/04/19for Q1 2023	In-house	Under $5,000	Health issues
23/01/19for Q4 2022	In-house	Under $5,000	Health issues